Abstract
Inflammatory bowel diseases, including Crohn’s Disease and Ulcerative Colitis, result from a dysregulated inflammatory response to environmental factors in genetically predisposed individuals. The list of genetic factors involved in the development of these diseases has considerably increased in last years. However, recently, new promising insights on inflammatory bowel diseases have been produced by studies on microRNAs. MicroRNAs are small non coding RNA molecules, that play a pivotal role in gene expression and regulation. They are involved in many biological processes, such as cellular proliferation and differentiation, signal transduction and, more recently, they have been recognized as also having a role in the innate and adaptative response. In this review we give an overview on the role of microRNAs in the pathogenesis of inflammatory bowel diseases.
Keywords: Crohn’s disease (CD), gene expression, genetic variability, inflammatory bowel diseases (IBD), microRNAs, susceptibility, ulcerative Colitis (UC).
Graphical Abstract
MicroRNA
Title:Advances in Exploring the Role of Micrornas in Inflammatory Bowel Disease
Volume: 5 Issue: 1
Author(s): Cinzia Ciccacci*, Cristina Politi, Giuseppe Novelli and Paola Borgiani
Affiliation:
- Department of Biomedicine and Prevention, Section of Genetics, School of Medicine, University of Rome “Tor Vergata”, Rome, Italy.,Italy
Keywords: Crohn’s disease (CD), gene expression, genetic variability, inflammatory bowel diseases (IBD), microRNAs, susceptibility, ulcerative Colitis (UC).
Abstract: Inflammatory bowel diseases, including Crohn’s Disease and Ulcerative Colitis, result from a dysregulated inflammatory response to environmental factors in genetically predisposed individuals. The list of genetic factors involved in the development of these diseases has considerably increased in last years. However, recently, new promising insights on inflammatory bowel diseases have been produced by studies on microRNAs. MicroRNAs are small non coding RNA molecules, that play a pivotal role in gene expression and regulation. They are involved in many biological processes, such as cellular proliferation and differentiation, signal transduction and, more recently, they have been recognized as also having a role in the innate and adaptative response. In this review we give an overview on the role of microRNAs in the pathogenesis of inflammatory bowel diseases.
Export Options
About this article
Cite this article as:
Ciccacci Cinzia*, Politi Cristina, Novelli Giuseppe and Borgiani Paola, Advances in Exploring the Role of Micrornas in Inflammatory Bowel Disease, MicroRNA 2016; 5 (1) . https://dx.doi.org/10.2174/2211536605666160111124812
DOI https://dx.doi.org/10.2174/2211536605666160111124812 |
Print ISSN 2211-5366 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5374 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
p42.3: An Abductor of Cell Cycle
Anti-Cancer Agents in Medicinal Chemistry Context-dependent Action of Transforming Growth Factor β Family Members on Normal and Cancer Stem Cells
Current Pharmaceutical Design Oncolytic Viruses: The Best is Yet to Come
Current Cancer Drug Targets The Possible Role of Infertility Drugs in Later Malignancy: A Review
Current Medicinal Chemistry Resistance to Anti-VEGF Agents
Current Pharmaceutical Design Bringing Light into the Diagnosis of Skin Disorders - Short Review on Laser Induced Fluorescence Spectroscopy and Optical Coherence Tomography in Dermatology
Current Medical Imaging Cyclin-Dependent Kinase Inhibition by Flavoalkaloids
Mini-Reviews in Medicinal Chemistry Tumor Immune Escape Mechanisms that Operate During Metastasis
Current Pharmaceutical Biotechnology A Review of Transdermal Drug Delivery Using Nano-Vesicular Carriers: Transfersomes
Recent Patents on Nanomedicine The Dichloromethane Fraction of <i>Vernonia cinerea</i> Impart Pro-Apoptotic, Genotoxic, Cell Cycle Arrest, and Drug Efflux Inhibitory Effects on Human Adenocarcinoma Cells
Recent Patents on Anti-Cancer Drug Discovery Proteomics Approach to Illustrate Drug Action Mechanisms
Current Drug Discovery Technologies New Cathepsin D Inhibitor Library Utilizing Hydroxyethyl Isosteres with Cyclic Tertiary Amines
Medicinal Chemistry Thermosensitive Polymeric Hydrogels As Drug Delivery Systems
Current Medicinal Chemistry Iron and Iron Chelators: A Review on Potential Effects on Skin Aging
Current Aging Science Manipulating Thymic Apoptosis for Future Therapy of Autoimmune Diseases
Current Pharmaceutical Design Inflammatory Mediators Hold the Key to Dendritic Cell Suppression and Tumor Progression
Current Medicinal Chemistry Selenium Compounds and Apoptotic Modulation: A New Perspective in Cancer Therapy
Mini-Reviews in Medicinal Chemistry Combination of Anti-EGFR Drugs with Anti-Angiogenic or Other Signal Transduction Inhibitors as a Rational Approach to Cancer Therapy
Current Cancer Therapy Reviews High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer
Recent Patents on Anti-Cancer Drug Discovery Trends and Prospects of Plant Proteases in Therapeutics
Current Medicinal Chemistry